516
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Auditory neuropathy in late preterm infants treated with phototherapy for hyperbilirubinemia

, , &
Pages 89-95 | Received 10 Oct 2012, Accepted 22 Jun 2014, Published online: 26 Aug 2014

References

  • Abdala C. 2004. Distortion product otoacoustic emission (2f1-f2) suppression in three-month-old infants: Evidence for postnatal maturation of human cochlear function? J Acoust Soc Am, 116(6), 3572–3580.
  • Akman I., Ozek E., Kulekci S., Turkdogan D., Cebeci D. et al. 2004. Auditory neuropathy in hyperbilirubinemia: Is there a correlation between serum bilirubin, neuron-specific enolase levels, and auditory neuropathy? Int J Audiol, 43, 516–522.
  • American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. 2004. Management of hyperbilirubinemia in the newborn infant of 35 or more weeks of gestation. Pediatrics, 114(1), 297–316.
  • Baradaranfar M.H., Atighechi S., Dadgarnia M.H., Jafari R., Karimi G. et al. 2011. Hearing status in neonatal hyperbilirubinemia by auditory brainstem. Evoked response and transient evoked otoacoustic emission. Acta Med Iran, 49, 109–112.
  • Berlin C.I., Morlet T. & Hood L.J. 2003. Auditory neuropathy/dyssynchrony: Its diagnosis and management. Pediatr Clin North Am, 50(2), 331–340.
  • Berlin C.I., Hood J.L., Morlet T., Wilensky D., Li L. et al. 2010. Multi-site diagnosis and management of 260 patients with auditory neuropathy/dys-synchrony (auditory neuropathy spectrum disorder). Int J Audiol, 49, 30–43.
  • Bhutani V.K., Johnson L. & Sivieri E.M. 1999. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics, 103, 6–14.
  • Bonfils P., Francois M., Avan P., Londero A., Trotoux J. et al. 1992. Spontaneous and evoked otoacoustic emissions in preterm neonates. Laryngoscope, 102, 182–186.
  • Chisin R., Pearman M. & Sohmer H. 1979. Cochlear and brainstem responses in hearing loss following neonatal hyperbilirubinemia. Ann Otol Rhinol Laryngol, 81, 352–357.
  • Clarós P., Turcanu D., Caballero M., Costa C., Clavería M.A. et al. 2003. Sensorineural hearing loss due to neonatal hyperbilirubinemia. Acta Otorhinolaryngol Esp, 54, 393–398.
  • Deltenre P., Mansbach A.L., Bozet C., Clerex A. & Hecox K.E. 1997. Auditory neuropathy: A report on three cases with early onsets and major neonatal illnesses. Electroencephalogr Clin Neurophysiol, 104, 17–22.
  • Deltenre P., Mansbach A.L., Bozet C., Christiaens F., Barthelemy P. et al. 1999. Auditory neuropathy with preserved cochlear microphonics and secondary loss of otoacoustic emissions. Audiology, 38, 187–195.
  • De Vries L.S., Lary S., Whitelaw A.G. & Dubowitz L.M. 1987. Relationship of serum bilirubin levels and hearing impairment in newborn infants. Early Hum Dev, 15, 269–277.
  • Funato M., Tamai H., Shimada S. & Nakamura H. 1994, Vigitiphobia, unbound bilirubin, and auditory brainstem responses. Pediatrics, 93, 50–53.
  • Haustein M.D., Read D.J., Steinert J.R., Pilati N., Dinsdale D. et al. 2010. Acute hyperbilirubinemia induces presynaptic neurodegeneration at a central glutamatergic synapse. J Physiol, 588, 4683–4693.
  • Hood L.J., Berlin C.I., Bordelon J. & Rose K. 2003. Patients with auditory neuropathy/dys-synchrony lack efferent suppression of transient evoked otoacoustic emissions. J Am Acad Audiol, 14, 302–313.
  • Hung K.L. 1989. Auditory brainstem responses in patients with neonatal hyperbilirubinemia and bilirubin encephalopathy. Brain Dev, 11, 297–301.
  • Kirkim G., Serbetcioglu B., Erdag T.K. & Ceryan K. 2008. The frequency of auditory neuropathy detected by universal newborn hearing screening program. Int J Pediatr Otorhinolaryngol, 72, 1461–1469.
  • Kok M.R., van Zanten G.A. & Brocaar M.P. 1993. Click-evoked oto-acoustic emissions (EOAEs) in 1036 ears of healthy newborns. Audiology, 32, 213–224.
  • Luo R.Z., Wen R.J., Huang Z.Y., Zhou J.L. & Wang X.Y. et al. 2008. Audiological characteristics and localization of lesions in children with retrocochlear auditory nerve impairment. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 43, 336–340.
  • Madden C., Rutter M., Hilbert L., Greinwald J.H. Jr. & Choo D.I. 2002. Clinical and audiological features in auditory neuropathy. Arch Otolaryngol Head Neck Surg, 128, 1026–1030.
  • Mason J.A. & Herrmann K.R. 1998. Universal infant hearing screening by automated auditory brainstem response measurement. Pediatrics, 101, 221–228.
  • Oğün B., Serbetçioğlu B., Duman N., Ozkan H. & Kirkim G. 2003. Long-term outcome of neonatal hyperbilirubinemia: Subjective and objective audiological measures. Clin Otolaryngol Allied Sci, 28, 507–513.
  • Rance G., Beer D.E., Cone-Wesson B., Shepherd R.K., Dowell R.C. et al. 1999. Clinical findings for a group of infants and young children with auditory neuropathy. Ear Hear, 20, 238–252.
  • Rance G. 2005. Auditory neuropathy/dys-synchrony and its perceptual consequences. Trends Amplif, 9, 1–43.
  • Rapin I., Gravel J. 2003. ‘Auditory neuropathy’: Physiologic and pathologic evidence calls for more diagnostic specificity. Int J Pediatr Otorhinolaryngol, 67, 707–728.
  • Raveh E., Buller N., Badrana O. & Attias J. 2007. Auditory neuropathy: Clinical characteristics and therapeutic approach. Am J Otolaryngol, 28, 302–308.
  • Rhee C.K., Park H.M. & Jang Y.J. 1999. Audiologic evaluation of neonates with severe hyperbilirubinemia using transiently evoked otoacoustic emissions and auditory brainstem responses. Laryngoscope, 109, 2005–2008.
  • Saluja S., Agarwal A., Kler N. & Amin S. 2010. Auditory neuropathy spectrum disorder in late preterm and term infants with severe jaundice. Int J Pediatr Otorhinolaryngol, 74, 1292–1297.
  • Shapiro S.M. & Popelka G.R. 2011. Auditory impairment in infants at risk for bilirubin-induced neurologic dysfunction. Semin Perinatol, 35, 162–170.
  • Sheykholeslami K. & Kaga K. 2000. Otoacoustic emissions and auditory brainstem responses after neonatal hyperbilirubinemia. Int J Pediatr Otorhinolaryngol, 52, 65–73.
  • Starr A., Sininger Y., Nguyen T., Michalewski H.J., Oba S. et al. 2001. Cochlear receptor (microphonic and summating potentials, otoacoustic emissions) and auditory pathway (auditory brainstem potentials) activity in auditory neuropathy. Ear Hear, 22, 91–99.
  • Starr A., Sininger Y.S. & Pratt H. 2000. The varieties of auditory neuropathy. J Basic Clin Physiol Pharmacol, 11, 215–230.
  • Stein L., Tremblay K., Pasternak J., Banerjee S., Lindemann K. et al. 1996. Brainstem abnormalities in neonates with normal otoacoustic emissions. Semin Hear, 17, 197–213.
  • Suppiej A., Rizzardi E., Zanardo V., Franzoi M., Ermani M. et al. 2007. Reliability of hearing screening in high-risk neonates: Comparative study of otoacoustic emission, automated and conventional auditory brainstem response. Clin Neurophysiol, 118, 869–876.
  • Wang M.L., Dorer D.J., Fleming M.P. & Catlin E.A. 2004. Clinical outcomes of near-term infants. Pediatrics, 114, 372.
  • Xu Z.M., Cheng W.X. & Yang X.L. 2011. Performance of two hearing screening protocols in NICU in Shanghai. Int J Pediatr Otorhinolaryngol, 75, 1225–1229.
  • Yoshinaga-Itano C., Sedey A.L., Coulter D.K. & Mehl A.L. 1998. Language of early- and later-identified children with hearing loss. Pediatrics, 102, 1161–1171.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.